Finance 24 February 2026

GeneDx stock slips premarket as analysts trim targets after 2025 results and 2026 outlook
···

GeneDx stock slips premarket as analysts trim targets after 2025 results and 2026 outlook

GeneDx Holdings shares fell 0.5% in premarket trading Tuesday after the company reiterated its 2026 outlook and reported 2025 revenue of $427.5 million. The company disclosed a material weakness in IT controls, with Ernst & Young issuing an adverse opinion on internal financial reporting. BTIG and TD Cowen both cut price targets but kept Buy ratings. GeneDx ended 2025 with $172.3 million in cash.
February 24, 2026
Kinross Gold stock jumps 6% on gold rally — what to watch before the U.S. open
···

Kinross Gold stock jumps 6% on gold rally — what to watch before the U.S. open

Kinross Gold closed up 6.2% at $35.53 Monday as gold surged to a three-week high, then slipped 1.1% Tuesday to $5,174.68 an ounce as the dollar rose. Kinross last week reported record $2.5 billion free cash flow and raised its dividend 14%, with a $0.04 payout set for March 26. U.S. stock futures edged higher premarket. Traders are watching tariff headlines and Fed remarks.
February 24, 2026
Oceaneering (OII) stock pushes higher premarket after Barclays target hike — what to watch next
···

Oceaneering (OII) stock pushes higher premarket after Barclays target hike — what to watch next

Oceaneering International shares rose 1.83% to $37.90 in Tuesday premarket trading after a 6.98% gain Monday, following a Barclays price target hike to $32. The company last week forecast 2026 EBITDA of $390–$440 million and free cash flow of $100–$120 million. Management flagged a seasonally soft first quarter and a working-capital cash draw. CFO and COO will meet investors at the THRIVE Energy Conference on Feb. 26.
February 24, 2026
Fortuna Mining stock dips premarket after a 52-week high run — what traders are watching
···

Fortuna Mining stock dips premarket after a 52-week high run — what traders are watching

Fortuna Mining shares fell 2.5% to $13.01 in premarket trading Tuesday, after jumping 8.7% the previous session. Spot gold dropped over 1% as the dollar strengthened, reversing Monday’s safe-haven rally. Fortuna last week reported record free cash flow and a 73% increase in indicated gold resources at its Diamba Sud project in Senegal. Investors remain focused on cash generation and project approvals.
February 24, 2026
Tidewater stock jumps before U.S. open after $500 million Brazil vessel deal
···

Tidewater stock jumps before U.S. open after $500 million Brazil vessel deal

Tidewater shares rose 7.6% to $78.91 in extended trading after it agreed to buy Brazil’s Wilson Sons Ultratug Offshore and Atlantic Offshore Services for about $500 million, including debt. The deal adds 22 platform supply vessels and $441 million in contracted backlog. Tidewater expects $220 million in revenue from the acquired business in the first year. Investors await Brazil antitrust and lender approvals before a late-Q2 close.
February 24, 2026
Veris Residential (VRE) stock hovers below $19 buyout price in premarket — what traders watch next
···

Veris Residential (VRE) stock hovers below $19 buyout price in premarket — what traders watch next

Veris Residential agreed to be acquired by Affinius Capital and Vista Hill Partners for $19 a share in cash. Shares hovered near $18.80 in premarket trading after a 12% jump Monday. Veris canceled its earnings call and suspended 2026 guidance while the deal is pending. The company reported Q4 core FFO of $0.19 a share and full-year 2025 FFO of $0.72.
February 24, 2026
Netflix stock steadies premarket as Paramount lifts Warner bid and Trump heat hangs over NFLX
···

Netflix stock steadies premarket as Paramount lifts Warner bid and Trump heat hangs over NFLX

Netflix shares rose 0.4% to $76.33 in premarket trading Tuesday after a 3.4% drop Monday. Paramount Skydance submitted a higher, undisclosed offer for Warner Bros Discovery, challenging Netflix’s $27.75-per-share deal. Political scrutiny increased after Donald Trump called for the removal of Netflix director Susan Rice. UK regulators announced new content rules for streaming platforms including Netflix.
February 24, 2026
Amazon stock slides after $12 billion Louisiana data-center plan as AI spending fears linger
···

Amazon stock slides after $12 billion Louisiana data-center plan as AI spending fears linger

Amazon shares fell 2.3% to $205.27 after the company announced a $12 billion data-center project in Louisiana, part of a 2026 capital spending plan expected to reach $200 billion. The stock is down 9.4% this year. Investors await Nvidia’s earnings Wednesday for signals on AI infrastructure demand. Amazon said the Louisiana buildout will create 540 full-time jobs and fund $400 million for local water infrastructure.
February 24, 2026
B2Gold stock price in focus: CEO Johnson to retire, CFO Cinnamond tapped; BTG slips premarket
···

B2Gold stock price in focus: CEO Johnson to retire, CFO Cinnamond tapped; BTG slips premarket

B2Gold shares fell about 2% in premarket trading after the company announced founder and CEO Clive Johnson will retire in June, with CFO Mike Cinnamond set to take over. The leadership change comes as gold prices slipped over 1% Tuesday, pressuring mining stocks. Board chair Kelvin Dushnisky became executive chair last week. B2Gold expects 2026 gold output of 820,000 to 970,000 ounces.
February 24, 2026
Denison Mines stock wobbles premarket as traders wait on Phoenix mine next steps
···

Denison Mines stock wobbles premarket as traders wait on Phoenix mine next steps

Denison Mines shares slipped 0.2% to $4.18 in premarket trading Tuesday after a 3.2% gain Monday, following last week’s federal licence to begin building the Phoenix uranium project in Saskatchewan. The licence, valid until 2031, allows construction but not operations. Volume was thin at 1,880 shares. Investors await updates on the company’s final investment decision and construction timeline.
February 24, 2026
Tesla stock price dips below $400 as tariff shift and robotaxi risk frame the week
···

Tesla stock price dips below $400 as tariff shift and robotaxi risk frame the week

Tesla shares fell 2.9% to $399.83 on Monday as U.S. markets dropped amid new tariff concerns and scrutiny of assisted driving technology. U.S. Customs imposed a 10% tariff on some imports after a Trump proclamation, with the rate possibly rising to 15%. European data showed Tesla registrations fell 17% in January, while rival BYD’s surged 165%. Investors await U.S. consumer confidence data and Nvidia earnings this week.
February 24, 2026
ImmunityBio stock price: IBRX ticks up in premarket after ANKTIVA sales surge and new approvals
···

ImmunityBio stock price: IBRX ticks up in premarket after ANKTIVA sales surge and new approvals

ImmunityBio shares rose about 1% premarket Tuesday after reporting 2025 ANKTIVA net product revenue of $113 million, up 700% year over year. The stock surged 13% Monday on heavy volume. ANKTIVA is now authorized for bladder cancer in 33 countries and recently received conditional approval for lung cancer in Saudi Arabia. The company ended 2025 with a net loss of $351.4 million and $242.8 million in cash.
February 24, 2026
Cadence stock faces Tuesday test after Hexagon deal closes and new shares hit tape
···

Cadence stock faces Tuesday test after Hexagon deal closes and new shares hit tape

Cadence Design Systems issued 3.2 million shares to help fund its €2.7 billion purchase of Hexagon’s design-and-engineering unit, according to an SEC filing. The stock dropped 5.6% Monday, closing at $279.80. Cadence expects the deal to dilute 2026 non-GAAP EPS by 28 cents, turning accretive in 2027. The acquisition adds $160 million to projected 2026 revenue.
February 24, 2026
Vir Biotechnology stock jumps 60%+ premarket on Astellas deal, upbeat VIR-5500 data
···

Vir Biotechnology stock jumps 60%+ premarket on Astellas deal, upbeat VIR-5500 data

Vir Biotechnology shares rose about 64% premarket after announcing a prostate cancer drug partnership with Astellas Pharma, bringing $335 million upfront and up to $1.37 billion in milestones. Updated Phase 1 data for VIR-5500 showed 82% of PSA-evaluable patients had at least a 50% PSA drop. Vir expects its cash to fund operations into Q2 2028. Fourth-quarter 2025 revenue reached $64.1 million, up from $12.4 million.
February 24, 2026
1 … 70 71 72 73 74 … 140